In malignant choroidal melanoma will a delay in radical treatment influence prognosis?

Area of Science:

• Ophthalmology
• Oncology
• Medical Statistics

Background:

• Choroidal malignant melanoma is a rare intraocular tumor.
• Understanding prognostic factors and treatment timing is crucial for patient outcomes.
• Previous studies have not extensively analyzed outcomes based on prolonged observation periods prior to enucleation.

Purpose of the Study:

• To evaluate the impact of extended observation periods (≥3 years) before enucleation on the prognosis of choroidal malignant melanoma.
• To compare mortality rates in patients with prolonged observation versus the general series.
• To analyze risk factors influencing outcomes in this specific subgroup.

Main Methods:

• Retrospective analysis of 568 patients diagnosed with choroidal malignant melanoma.
• Identification of a subgroup (36 patients) with a history of at least 4 years prior to enucleation.
• Computer analysis of risk factors and their correlation with patient prognosis and mortality.

Main Results:

• No significant increase in mortality was observed in the subgroup of 36 patients with prolonged observation (≥3 years) compared to the entire cohort.
• The peak mortality following enucleation was consistent between the observed subgroup and the overall series.
• Computer analysis did not reveal a worsening prognosis associated with the extended observation period.

Conclusions:

• Prolonged observation periods prior to enucleation for choroidal malignant melanoma do not appear to negatively impact patient mortality.
• The timing of enucleation, even after extended observation, does not alter the post-operative mortality pattern.
• Further research may explore the specific benefits or implications of watchful waiting in select choroidal melanoma cases.